Vaccine against pandemic strains of influenza viruses

Details for Australian Patent Application No. 2012216357 (hide)

Owner The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Purdue Research Foundation

Inventors Sambhara, Suryaprakash; Katz, Jacqueline; Hoelscher, Mary; Mittal, Suresh K.; Bangari, Dinesh S.

Agent Griffith Hack

Pub. Number AU-A-2012216357

Parent 2006236910

Filing date 22 August 2012

Wipo publication date 13 September 2012

International Classifications

C12N 7/00 Viruses, e.g. bacteriophages

A61K 39/145 Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

C07K 14/11 Peptides having more than 20 amino acids

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/861 Mutation or genetic engineering - Adenoviral vectors

Event Publications

6 September 2012 Complete Application Filed

13 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216357

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216358-Process For Preparing Oxymorphone, Naltrexone and Buprenorphine

2012216356-A Packing Plug